Robert Duggan
$11.9B
Born
Apr 28, 1944
Age
81
Source of Wealth
Pharmaceuticals
Residence
Clearwater, Florida
Citizenship
United States
Marital Status
Married
Children
8
Education
Drop Out, University of California, Los Angeles; Drop Out, University of California, Santa Barbara
- In 2020, Robert Duggan invested $63 million in Nasdaq-listed Summit Therapeutics and became its Co-CEO, leading the biotech in developing targeted oncology therapies for difficult diagnoses.
- Pharmacyclics' cancer drug Imbruvica made Duggan a billionaire in 2013 and paved the way for the company's $21 billion sale to AbbVie in 2015.
- Duggan, whose son died from brain cancer, became passionate about Pharmacyclic's cancer fighting drugs and first invested in 2004.
- His enthusiasm for investing began four decades earlier in a corporate finance class he took at the University of California at Santa Barbara.
- In 2020, Duggan bought $63 million of shares in Nasdaq-listed Summit Therapeutics, a small biotech company, and became its CEO.
- Duggan also sits on the board of Pulse Biosciences, of which he is the largest individual shareholder.
- Duggan is a big donor to the Church of Scientology, of which he is a member; he says he's given the church nearly $360 million over his lifetime.
- Duggan enjoys surfing in his spare time.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|